A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention
Bin Nie, Wan-Jun Cheng, Yan-Fang Li, Zheng Cao, Qing Yang, Ying-Xin Zhao, Yong-He Guo, Yu-Jie ZhouТом:
72
Рік:
2008
Мова:
english
Сторінки:
8
DOI:
10.1002/ccd.21713
Файл:
PDF, 174 KB
english, 2008